Outlook Therapeutics, Inc. (Outlook Therapeutics, or the Company) (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union and the United Kingdom for the ...
Dr. Frenkel highlights a comprehensive program that covers the latest breakthroughs in glaucoma and cataract surgery to in-depth discussions on AI, retinal treatments, and new drug-delivery platforms, ...
Aging Population and Pipeline Launches Fuel Rapid Growth in Ophthalmic Pharma MarketDublin, Jan. 13, 2025 (GLOBE NEWSWIRE) -- The "Ophthalmic Drugs Market Report 2025-2035" has been added to ...
A workshop at the AOP’s Locum clinical skills conference 2024 discussed the importance of patient communication when taking OCT scans – and offered reassurance that every optometrist does not need to ...
Pharmaceuticals announced the appointment of Reginald Sanders to its Board of Directors. Sanders is a distinguished retina ...
WATERTOWN, Mass., Jan. 08, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal ...
The FDA has approved a first-of-its-kind treatment for dry age-related macular degeneration (AMD), a leading cause of blindness in adults over 55.
Cencora has acquired an interest in RCA of approximately 85%, with certain RCA physicians and members of the management team retaining a minority equity interest in the company.
CONSHOHOCKEN, PA — Cencora, Inc. (NYSE: COR) announced it has finalized its acquisition of Retina Consultants of America (RCA ...
Rural areas are increasingly facing ophthalmic subspecialty surgeon shortages, according to a study published online Ja ...
Lana Rifkin, MD, a uveitis specialist at Ophthalmic Consultants of Boston, shared insights into her work and her role as ...
From stitching up childhood scrapes to guiding us through life’s most challenging diagnoses, doctors are the backbone of our health and well-being. Few decisions carry as much weight as choosing the ...